Fundamental Analysis
56 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +361.1% | +82.3% | 1 / 3 | +33.0% | -0.40 pp | +1.97 pp | +10.3% | 2.16 | 5.72 | 750 | +33,0% | 20,8 | +361,1% | 5.72 | 8.98 | −36,3% |
| Pts | 12 | 12 | 4 | 12 | 4 | 8 | 0 | -4 | 12 | |||||||
Valuation annotation:Price: 8.300 (close price on 2026-10-19)EPS (TTM): 1.450
Financial charts
1.Revenue & growth
VND bn750Q2/26
1.Revenue & growth
VND bn750Q2/26
2.Profit & growth
VND bn21,0Q2/26
3.Profit mix (Penman)
VND bn67,3Q2/26
4.Margins & cost structure
%10.8%Q2/26
5.Returns & cash cycle
% · days5.4%Q2/26
6.Earnings quality & cash
VND bn333Q2/26
7.Asset structure
VND bn2.310Q2/26
8.Funding & debt health
VND bn · times2.310Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %5,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %566Q2/26
Adjusted EPS growth, latest quarter
365%
Average adjusted EPS growth, 3 quarters
83.5%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26